ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Post COVID Pulmonary Fibrosis: What, Why and Whom?

Journal: International Journal of Science and Research (IJSR) (Vol.10, No. 7)

Publication Date:

Authors : ;

Page : 1217-1223

Keywords : Idiopathic Pulmonary Fibrosis; IPF; Non Specific Interstitial Pneumonia; NSIP; Organizing Pneumonia; COP; Bronchiolitis Obliterens Organizing Pneumonia; (BOOP; Organizing Pneumonia; Pneumocytes; Epithelial Type II Pneumocyte Dysfunction; Epithelial Type I;

Source : Downloadexternal Find it from : Google Scholarexternal


Post COVID-19 pulmonary fibrosis is a new condition which is being recognized increasingly in few patients of COVID diseases. Though the actual prevalence is still unknown, but more patients are being detected of having this condition with increasing number of cases. Patients usually present with persistent shortness of breath even after recovery from other COVID related symptoms. The HRCT shows organizing pneumonia, traction bronchiectasis and ground glass opacities (GGOs). Injury to Type II Pneumocytes by the virus may be the inciting event. The treatment of the condition is still unknown, but various drugs have been tried.

Last modified: 2021-08-15 12:57:31